Brulidine

Pays: Nouvelle-Zélande

Langue: anglais

Source: Medsafe (Medicines Safety Authority)

Ingrédients actifs:

Dibrompropamidine isetionate 0.15%{relative}

Disponible depuis:

sanofi-aventis new zealand limited

DCI (Dénomination commune internationale):

Dibrompropamidine isetionate 0.15% w/w

Dosage:

0.15 %

forme pharmaceutique:

Topical cream

Composition:

Active: Dibrompropamidine isetionate 0.15%{relative} Excipient: Castor oil Cetostearyl alcohol Compound 225 Macrogol 600 Methyl hydroxybenzoate Purified water Simeticone

Unités en paquet:

Jar, plastic, 1x250g, 250 g

classe:

General sale

Type d'ordonnance:

General sale

Fabriqué par:

Aventis Pharma Dagenham Ltd

Descriptif du produit:

Package - Contents - Shelf Life: Jar, plastic, 1x250g - 250 g - 36 months from date of manufacture stored at or below 25°C - Tube, aluminium, - 15 g - 36 months from date of manufacture stored at or below 25°C - Tube, aluminium, - 25 g - 36 months from date of manufacture stored at or below 25°C

Date de l'autorisation:

1969-12-31